Pentavere, a subsidiary of HEALWELL AI, has been nominated for the 2026 International Prix Galien Award in the Best Startup category following its 2024 Prix Galien USA win. This nomination places DARWEN™ AI among top global healthcare innovations from major companies like AstraZeneca and Pfizer, validating its role in transforming clinical data into actionable intelligence. The recognition highlights DARWEN™'s potential to scale AI-driven disease detection and clinical research worldwide, supported by HEALWELL's expanding healthcare technology ecosystem. This milestone strengthens HEALWELL's position in the global healthcare AI market and underscores its commitment to improving patient outcomes through advanced AI solutions.
Kenon Holdings Ltd. is benefiting from favorable market conditions in the US PJM energy market and improving margins in its Israeli business through OPC Energy. The company is expanding capacity and margins, supporting long-term growth. It currently ...
Bitcoin's price pulled back to about $64,300 after failing to sustain a rise above $65,000, facing resistance near $65,400 and weak spot demand. Trading volume on spot markets remains low, while futures dominate activity, increasing volatility risks....
Kraken Robotics, a Canadian marine technology firm, benefits from increasing global defense spending driving demand for autonomous underwater systems. Its acquisition of Covelya broadens its product offerings and customer reach, despite short-term di...
CDN Maverick Capital Corp. is enhancing its investor communications to increase visibility as it advances exploration in Québec's James Bay and Rainbow Canyon projects. The company controls a large land position in James Bay, with the drill-ready Not...
Keysight Technologies reported a 37% revenue increase and 79% EPS growth in Q3, driven by rising AI-related demand. Orders surpassed $2 billion, supported by a strong backlog and book-to-bill ratio, indicating sustained revenue growth through at leas...
